Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05411822 · ClinicalTrials.gov registry record · NA
Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05411822 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 36 participants.
The verdict
NCT05411822, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate the relationship between light, the thickness of the pigment at the back of your eye, melatonin levels, and memory. The study will investigate whether changing light distribution pattern from "on-axis"' (i.e., directed along the eye's visual axis to the fovea) to "off-axis" (i.e., directed on the periphery of the eye's visual axis) impact melatonin suppression in 24 mild cognitive impairment participants and 24 healthy, age-matched controls.
Interventions
- DEVICE Lighting Intervention Blue light
- DEVICE Lighting Intervention Green light
- OTHER Dim-light control condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05411822
The ClinicalTrials.gov registry entry for NCT05411822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lighting Intervention Blue light is the first listed.
NCT05411822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05411822 about?
NCT05411822 is a clinical study titled "Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment". The purpose of this research study is to investigate the relationship between light, the thickness of the pigment at the back of your eye, melatonin levels, and memory. The study will investigate whether changing light distribution pattern from "on-axis"' (i.e., directed along the eye's visual axis ...
What is the current status of trial NCT05411822?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-06-14. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05411822?
The interventions under investigation include: Lighting Intervention Blue light (DEVICE), Lighting Intervention Green light (DEVICE), Dim-light control condition (OTHER).
Who is sponsoring clinical trial NCT05411822?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.